• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990年至2021年因高体重指数所致高血压性心脏病的全球负担:多维分析与公共卫生应对措施

Global burden of hypertensive heart disease attributable to high body mass index from 1990 to 2021: a multidimensional analysis and public health response.

作者信息

Sun Zhenhai, Zhang Rui, Cong Mingyang, Zhang Menghe, Lv Tailong, Xie Huidan, Chen Shouqiang

机构信息

Second School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.

Department of Acupuncture and Tuina, Dongying Shengli Oilfield Central Hospital, Dongying, China.

出版信息

Front Cardiovasc Med. 2025 Aug 12;12:1570390. doi: 10.3389/fcvm.2025.1570390. eCollection 2025.

DOI:10.3389/fcvm.2025.1570390
PMID:40873620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12379062/
Abstract

BACKGROUND

As the global population of obese individuals surpasses 878 million, the impact of high body mass index (BMI) on hypertensive heart disease (HHD) has risen to the third position among all diseases. However, the specific contribution of high BMI to the burden of HHD remains unclear.

METHODS

Data on deaths, disability-adjusted life years (DALYs), and their age-standardized rates (ASR) were obtained from the Global Burden of Disease (GBD) database. Population attributable fractions (PAF) was used to assess the contribution of risk factors. Various analytical methods, including decomposition analysis, cluster analysis, frontier analysis, age-period-cohort (APC) analysis, and Bayesian age-period-cohort (BAPC) analysis, were employed to investigate changes in disease burden.

RESULTS

The results showed an increasing global burden of HHD due to high BMI, with both mortality and DALYs doubling over the past 30 years. Their ASR also continued to rise. By 2021, the PAF for deaths and DALYs reached 44% and 49%, respectively. Population growth and aging were significant contributors to this disease burden. Low- and middle- Socio-Demographic Index (SDI) regions experienced the highest burden, particularly in East Asia, South Asia, North Africa and Middle East. Although the disease burden was lower in high-income areas, the increase was notable, especially in North America. Women and older populations faced higher risks, particularly alarming is the rapid increase in risk among younger populations in high SDI regions.

CONCLUSION

HHD resulting from high BMI poses a significant global public health challenge, particularly in regions with middle and low SDI. While the heightened risk among women and older individuals has garnered considerable attention, the increasing risk among younger populations also necessitates greater focus. Targeted interventions should prioritize diet, exercise, medical security, and health education, with particular emphasis on enhancing policy support for low-income and high-risk groups. Future policies must integrate the social, economic, and cultural contexts of each region, implement comprehensive prevention and control strategies, and establish a multi-dimensional health promotion system.

摘要

背景

随着全球肥胖人口超过8.78亿,高体重指数(BMI)对高血压性心脏病(HHD)的影响在所有疾病中已升至第三位。然而,高BMI对HHD负担的具体贡献仍不清楚。

方法

从全球疾病负担(GBD)数据库中获取死亡、伤残调整生命年(DALYs)及其年龄标准化率(ASR)的数据。人群归因分数(PAF)用于评估危险因素的贡献。采用了各种分析方法,包括分解分析、聚类分析、前沿分析、年龄-时期-队列(APC)分析和贝叶斯年龄-时期-队列(BAPC)分析,以研究疾病负担的变化。

结果

结果显示,由于高BMI导致的全球HHD负担不断增加,过去30年死亡率和DALYs均翻了一番。它们的ASR也持续上升。到2021年,死亡和DALYs的PAF分别达到44%和49%。人口增长和老龄化是这种疾病负担的重要促成因素。社会人口指数(SDI)低和中等的地区负担最高,特别是在东亚、南亚、北非和中东。虽然高收入地区的疾病负担较低,但增长显著,尤其是在北美。女性和老年人群面临更高风险,特别令人担忧的是高SDI地区年轻人群风险的快速上升。

结论

高BMI导致的HHD对全球公共卫生构成重大挑战,特别是在SDI中低的地区。虽然女性和老年人风险增加备受关注,但年轻人群风险增加也需要更多关注。有针对性的干预应优先考虑饮食、运动、医疗保障和健康教育,特别强调加强对低收入和高危群体的政策支持。未来政策必须结合各地区的社会、经济和文化背景,实施全面防控策略,建立多维健康促进体系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/7d94e84c986e/fcvm-12-1570390-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/2f78df8b68f1/fcvm-12-1570390-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/370cf271598e/fcvm-12-1570390-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/edd0e7810cc2/fcvm-12-1570390-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/3195c3018317/fcvm-12-1570390-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/f47e0a93194b/fcvm-12-1570390-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/aece86aa24f2/fcvm-12-1570390-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/56e932e75ddd/fcvm-12-1570390-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/209465b362d3/fcvm-12-1570390-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/edda1848577c/fcvm-12-1570390-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/f9a9d81afd99/fcvm-12-1570390-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/3fa0d0dfc062/fcvm-12-1570390-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/773855a94ba1/fcvm-12-1570390-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/7d94e84c986e/fcvm-12-1570390-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/2f78df8b68f1/fcvm-12-1570390-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/370cf271598e/fcvm-12-1570390-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/edd0e7810cc2/fcvm-12-1570390-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/3195c3018317/fcvm-12-1570390-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/f47e0a93194b/fcvm-12-1570390-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/aece86aa24f2/fcvm-12-1570390-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/56e932e75ddd/fcvm-12-1570390-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/209465b362d3/fcvm-12-1570390-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/edda1848577c/fcvm-12-1570390-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/f9a9d81afd99/fcvm-12-1570390-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/3fa0d0dfc062/fcvm-12-1570390-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/773855a94ba1/fcvm-12-1570390-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0bd/12379062/7d94e84c986e/fcvm-12-1570390-g013.jpg

相似文献

1
Global burden of hypertensive heart disease attributable to high body mass index from 1990 to 2021: a multidimensional analysis and public health response.1990年至2021年因高体重指数所致高血压性心脏病的全球负担:多维分析与公共卫生应对措施
Front Cardiovasc Med. 2025 Aug 12;12:1570390. doi: 10.3389/fcvm.2025.1570390. eCollection 2025.
2
Global burden trends and future predictions of ischemic heart disease attributable to air pollution in people aged 60 years and older, 1990-2021.1990 - 2021年60岁及以上人群中空气污染所致缺血性心脏病的全球负担趋势及未来预测
Front Public Health. 2025 Jul 4;13:1598092. doi: 10.3389/fpubh.2025.1598092. eCollection 2025.
3
Causal impact of obesity class stratification and endometrial cancer subtypes: an integrated mendelian randomization and global burden of disease study 2021 analysis.肥胖分级与子宫内膜癌亚型的因果影响:2021年孟德尔随机化与全球疾病负担研究的综合分析
Int J Surg. 2025 Jun 27. doi: 10.1097/JS9.0000000000002883.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Global, regional, and national burden of maternal disorders, 1990-2021: a systematic analysis from the global burden of disease study 2021.1990 - 2021年全球、区域和国家孕产妇疾病负担:全球疾病负担研究2021的系统分析
BMC Public Health. 2025 Jul 29;25(1):2576. doi: 10.1186/s12889-025-23814-w.
6
The global burden of depression attributable to childhood sexual abuse, intimate partner violence, and bullying victimization from 1990 to 2021: an analysis based on the global burden of disease study.1990年至2021年期间,童年期性虐待、亲密伴侣暴力和受欺凌所致抑郁症的全球负担:基于全球疾病负担研究的分析
Ann Gen Psychiatry. 2025 Aug 6;24(1):47. doi: 10.1186/s12991-025-00586-6.
7
Burden of knee osteoarthritis in China and globally: 1990-2045.中国及全球膝关节骨关节炎负担:1990 - 2045年
BMC Musculoskelet Disord. 2025 Jul 1;26(1):582. doi: 10.1186/s12891-025-08858-8.
8
Global, regional, and national temporal trend in burden of chronic respiratory diseases from 1990 to 2021: Findings from the Global Burden of Disease Study 2021.1990年至2021年慢性呼吸道疾病负担的全球、区域和国家时间趋势:全球疾病负担研究2021的结果
Chin Med J (Engl). 2025 Aug 29. doi: 10.1097/CM9.0000000000003670.
9
Ischemic stroke in the context of high low-density lipoprotein cholesterol: A 30-year global burden perspective of 204 nations.高低密度脂蛋白胆固醇背景下的缺血性卒中:204个国家30年的全球负担视角
J Stroke Cerebrovasc Dis. 2025 Aug 6;34(10):108418. doi: 10.1016/j.jstrokecerebrovasdis.2025.108418.
10
Analysis of the burden of colorectal cancer attributable to high body mass index in 204 countries and regions worldwide from 1990 to 2021.1990年至2021年全球204个国家和地区因高体重指数导致的结直肠癌负担分析。
Front Nutr. 2025 Jun 9;12:1589250. doi: 10.3389/fnut.2025.1589250. eCollection 2025.

本文引用的文献

1
Global, regional, and national burden of brain and central nervous system cancer: a systematic analysis of incidence, deaths, and DALYS with predictions to 2040.全球、区域和国家脑及中枢神经系统癌症负担:发病率、死亡率和伤残调整生命年的系统分析及到2040年的预测
Int J Surg. 2025 Jun 1;111(6):4033-4038. doi: 10.1097/JS9.0000000000002359. Epub 2025 Apr 1.
2
Global, regional, and national burden of cutaneous malignant melanoma from 1990 to 2021 and prediction to 2045.1990年至2021年全球、区域和国家皮肤恶性黑色素瘤负担及2045年预测
Front Oncol. 2024 Dec 24;14:1512942. doi: 10.3389/fonc.2024.1512942. eCollection 2024.
3
The global, regional, and national alcohol-related colorectal cancer burden and forecasted trends: results from the global burden of disease study 2021.
全球、区域和国家酒精相关结直肠癌负担及预测趋势:2021年全球疾病负担研究结果
Front Nutr. 2024 Dec 24;11:1520852. doi: 10.3389/fnut.2024.1520852. eCollection 2024.
4
Global, regional, and national burden of myocarditis in children aged 0-14 years, 1990-2021: analysis for the global burden of disease study 2021.1990年至2021年0至14岁儿童心肌炎的全球、区域和国家负担:全球疾病负担研究2021分析
Front Public Health. 2024 Dec 20;12:1504586. doi: 10.3389/fpubh.2024.1504586. eCollection 2024.
5
Global, regional, and national burdens of heart failure in adolescents and young adults aged 10-24 years from 1990 to 2021: an analysis of data from the Global Burden of Disease Study 2021.1990年至2021年10至24岁青少年和青年人心力衰竭的全球、区域和国家负担:基于2021年全球疾病负担研究数据的分析
EClinicalMedicine. 2024 Dec 9;79:102998. doi: 10.1016/j.eclinm.2024.102998. eCollection 2025 Jan.
6
Global, regional, and national burdens of intracerebral hemorrhage and its risk factors from 1990 to 2021.1990年至2021年全球、区域和国家脑出血负担及其风险因素
Eur J Neurol. 2025 Jan;32(1):e70031. doi: 10.1111/ene.70031.
7
Global, Regional and National Burden of Maternal Obstructed Labour and Uterine Rupture, 1990-2021: Global Burden of Disease Study 2021.1990 - 2021年全球、区域和国家层面产妇梗阻性分娩及子宫破裂负担:2021年全球疾病负担研究
Paediatr Perinat Epidemiol. 2025 Feb;39(2):135-145. doi: 10.1111/ppe.13156. Epub 2024 Dec 10.
8
The burden, trends, and projections of low back pain attributable to high body mass index globally: an analysis of the global burden of disease study from 1990 to 2021 and projections to 2050.全球因高体重指数导致的腰痛负担、趋势及预测:对1990年至2021年全球疾病负担研究的分析及到2050年的预测
Front Med (Lausanne). 2024 Oct 23;11:1469298. doi: 10.3389/fmed.2024.1469298. eCollection 2024.
9
Community Paramedicine Program in Social Housing and Health Service Utilization: A Cluster Randomized Clinical Trial.社区医疗计划在社会住房和卫生服务利用中的应用:一项集群随机临床试验。
JAMA Netw Open. 2024 Oct 1;7(10):e2441288. doi: 10.1001/jamanetworkopen.2024.41288.
10
Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021.归因于高体重指数的疾病负担:对《2021年全球疾病负担研究》数据的分析
EClinicalMedicine. 2024 Sep 24;76:102848. doi: 10.1016/j.eclinm.2024.102848. eCollection 2024 Oct.